Anti-cancer agent comprising HVJ-E and CXCL2
US-10441613-B2 · Oct 15, 2019 · US
This page is not indexed by search engines while we improve data quality.
Patent family 58100151
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 58100151 |
| Family type | — |
| Earliest priority | Aug 24, 2015 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US10441613B2 — Anti-cancer agent comprising HVJ-E and CXCL2 |
Representative publication
Best representative member for this family based on priority and filing country.
US10441613B2 — Anti-cancer agent comprising HVJ-E and CXCL2 (published Oct 15, 2019)
Member publications
Related publications in this family.
Anti-cancer agent comprising hvj-e and cxcl2
US-2018243355-A1 · Aug 30, 2018 · US